Compositions and methods for immunooncology
US12037583B2 · kind B2 · utility
0Cited by
62References
55Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 2, 2016 |
| Grant date | Jul 16, 2024 |
| Priority date | — |
| Expiry date | Aug 9, 2039 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to genome editing systems, reagents and methods for immunooncology.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.